FDA Advisory Committee Recommends Approval For Qnexa

breaking news

Derma Tech - FREE Aveda Manicure with a Massage in June!
Get This Coupon
Chatter's Grill PITTSBURG KS 66762-6649 - WINEY WEDNESDAY! 1
Get This Coupon
Chatter's Grill PITTSBURG KS 66762-6649 - buy 1 large salad
Get This Coupon
Pet Warehouse - $5 Off Frontline Plus - Advantage II - Advan
Get This Coupon
WLT Windshield Repair - $25 Windshield Chip Repair
Get This Coupon
Gambinos Pizza - Joplin and Carl Junction - Gambino's Pizza
Get This Coupon
HACKETT HOT WINGS - Signature Sauces & Rubs In Restaurant an
Get This Coupon
fourstateshomepage - Robin Psajdl - Advertising Specials
Get This Coupon
Cosmic Castle Parsons KS - Grilled Cheese Meal at Cosmic Cas
Get This Coupon
Derma Tech - Botox $10.00 per Unit
Get This Coupon

By: MarketMinute.com Stock News

Posted on February 23, 2012 at 13:08 PM EST

A Food and Drug Administration advisory committee recommended approval for Vivus Inc.'s (Nasdaq: VVUS) obesity treatment Qnexa. The news also lifted rival Orexigen Therapeutics Inc. (Nasdaq: OREX). Shares of Vivus leaped $9.22 to $19.77 while Orexigen stock climbed 55 cents to $3.76.

Related Stocks:

Orexigen Therapeutics, Inc. Vivus, Inc.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates